Accéder au contenu
MilliporeSigma

Chronic exposure to low doses of pharmaceuticals disturbs the hepatic expression of circadian genes in lean and obese mice.

Toxicology and applied pharmacology (2014-02-15)
Sébastien Anthérieu, Dounia Le Guillou, Cédric Coulouarn, Karima Begriche, Viviane Trak-Smayra, Sophie Martinais, Mathieu Porceddu, Marie-Anne Robin, Bernard Fromenty
RÉSUMÉ

Drinking water can be contaminated with pharmaceuticals. However, it is uncertain whether this contamination can be harmful for the liver, especially during obesity. Hence, the goal of our study was to determine whether chronic exposure to low doses of pharmaceuticals could have deleterious effects on livers of lean and obese mice. To this end, lean and ob/ob male mice were treated for 4 months with a mixture of 11 drugs provided in drinking water at concentrations ranging from 10 to 10⁶ ng/l. At the end of the treatment, some liver and plasma abnormalities were observed in ob/ob mice treated with the cocktail containing 10⁶ ng/l of each drug. For this dosage, a gene expression analysis by microarray showed altered expression of circadian genes (e.g. Bmal1, Dbp, Cry1) in lean and obese mice. RT-qPCR analyses carried out in all groups of animals confirmed that expression of 8 different circadian genes was modified in a dose-dependent manner. For some genes, a significant modification was observed for dosages as low as 10²-10³ ng/l. Drug mixture and obesity presented an additive effect on circadian gene expression. These data were validated in an independent study performed in female mice. Thus, our study showed that chronic exposure to trace pharmaceuticals disturbed hepatic expression of circadian genes, particularly in obese mice. Because some of the 11 drugs can be found in drinking water at such concentrations (e.g. acetaminophen, carbamazepine, ibuprofen) our data could be relevant in environmental toxicology, especially for obese individuals exposed to these contaminants.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Erythromycin, BioReagent, suitable for cell culture
USP
Acétaminophène, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Caféine, anhydrous, 99%, FCC, FG
USP
Caféine, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Caféine, powder, ReagentPlus®
Sigma-Aldrich
Carbamazepine, powder
Supelco
Acétaminophène, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Salicylic acid, ACS reagent, ≥99.0%
Supelco
Caféine, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Caféine, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Salicylic acid, ≥99%, FG
Sigma-Aldrich
Salicylic acid, BioXtra, ≥99.0%
USP
Salicylic acid, United States Pharmacopeia (USP) Reference Standard
Supelco
Salicylic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Acétaminophène, BioXtra, ≥99.0%
Sigma-Aldrich
Salicylic acid, suitable for plant cell culture
Sigma-Aldrich
Acétaminophène, analytical standard
Supelco
Acetaminophen solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Acétaminophène, meets USP testing specifications, 98.0-102.0%, powder
Sigma-Aldrich
Erythromycin standard solution, 1 mg/mL in H2O
USP
Erythromycin, United States Pharmacopeia (USP) Reference Standard
Supelco
Sulfamethoxazole
Acétaminophène, European Pharmacopoeia (EP) Reference Standard
USP
Carbamazepine, United States Pharmacopeia (USP) Reference Standard
USP
Sulfamethoxazole, United States Pharmacopeia (USP) Reference Standard
Supelco
Caféine, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Caféine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
Sulfamethoxazole, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Caféine, Sigma Reference Standard, vial of 250 mg
Supelco
Salicylic acid, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®